LY3473329 (carbon-14 labelled)

LY3473329 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3473329 (carbon-14 labelled), covering 2024-05-30 to 2024-05-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male Participants [Phase 1]